"Binding Sites" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The parts of a macromolecule that directly participate in its specific combination with another molecule.
| Descriptor ID |
D001665
|
| MeSH Number(s) |
G02.111.570.120
|
| Concept/Terms |
Binding Sites- Binding Sites
- Site, Binding
- Sites, Binding
- Binding Site
- Combining Site
- Combining Sites
- Site, Combining
- Sites, Combining
|
Below are MeSH descriptors whose meaning is more general than "Binding Sites".
Below are MeSH descriptors whose meaning is more specific than "Binding Sites".
This graph shows the total number of publications written about "Binding Sites" by people in this website by year, and whether "Binding Sites" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 7 | 7 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 10 | 10 |
| 2006 | 0 | 16 | 16 |
| 2007 | 0 | 7 | 7 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 10 | 10 |
| 2010 | 0 | 8 | 8 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 8 | 8 |
| 2013 | 0 | 8 | 8 |
| 2014 | 0 | 6 | 6 |
| 2015 | 0 | 9 | 9 |
| 2016 | 0 | 9 | 9 |
| 2017 | 1 | 171 | 172 |
| 2018 | 2 | 124 | 126 |
| 2019 | 0 | 35 | 35 |
| 2020 | 0 | 69 | 69 |
| 2021 | 1 | 79 | 80 |
To return to the timeline, click here.
Below are the most recent publications written about "Binding Sites" by people in Profiles.
-
Rapidly emerging SARS-CoV-2 B.1.1.7 sub-lineage in the United States of America with spike protein D178H and membrane protein V70L mutations. Emerg Microbes Infect. 2021 Dec; 10(1):1293-1299.
-
Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein. Brief Bioinform. 2021 11 05; 22(6).
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants. Cell Res. 2021 10; 31(10):1126-1129.
-
Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion. Elife. 2021 08 31; 10.
-
Mechanical activation of spike fosters SARS-CoV-2 viral infection. Cell Res. 2021 10; 31(10):1047-1060.
-
PCA-based unsupervised feature extraction for gene expression analysis of COVID-19 patients. Sci Rep. 2021 08 30; 11(1):17351.
-
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife. 2021 08 26; 10.
-
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants. Cell Res. 2021 10; 31(10):1130-1133.
-
Binding of boswellic acids to functional proteins of the SARS-CoV-2 virus: Bioinformatic studies. Arch Pharm (Weinheim). 2021 Nov; 354(11):e2100160.